Related Experiment Video
Updated: Oct 19, 2025

Methodologies for Studying B. subtilis Biofilms as a Model for Characterizing Small Molecule Biofilm Inhibitors
Published on: October 9, 2016
The bacterial phylum Planctomycetes as novel source for bioactive small molecules
Nicolai Kallscheuer1, Christian Jogler2
1Institute of Bio- and Geosciences (IBG-1): Biotechnology, Forschungszentrum Jülich GmbH, Jülich, Germany; Department of Microbial Interactions, Institute of Microbiology, Friedrich Schiller University, Jena, Germany.
Exploring the Planctomycetes phylum reveals a rich source of novel antibiotics and biomedical compounds. Further research into this diverse bacterial group is crucial for future natural product discovery.
Area of Science:
- Bacterial cell biology
- Microbial biotechnology
- Natural product discovery
Background:
- Bacterial cell biology expertise has grown, integrating bacteria into biotechnological processes.
- Focusing on model bacteria for biotechnology overlooks the vast untapped bacterial diversity crucial for bioprospecting.
- The Planctomycetes phylum, an evolutionarily deep-branching group, is gaining attention for producing small molecules with biomedical activities, including novel antibiotics.
Purpose of the Study:
- To review the current state of Planctomycetes research, focusing on their diversity, small molecule production, and potential applications.
- To highlight the importance of exploring understudied bacterial phyla for natural product discovery.
- To emphasize the need to commence research on additional promising bacterial phyla for novel small molecule sources.
Main Methods:
- Initiated a large-scale sampling campaign over ten years ago to isolate Planctomycetes from diverse natural habitats.
- Developed specific protocols to overcome cultivation challenges for representative Planctomycetes species.
- Characterized approximately 90 novel strains, enabling in silico analysis of their genetic coding potential.
Main Results:
- Characterization of ~90 novel Planctomycetes strains provided insights into their genetic makeup and potential for producing bioactive compounds.
- Planctomycetes are emerging as a significant natural source for novel antibiotics and other small molecules with biomedical relevance.
- Next-generation sequencing and metagenomics complement classical isolation, offering access to genomes of uncultivated bacteria.
Conclusions:
- Planctomycetes represent a promising, yet underexplored, phylum for discovering novel small molecules with biomedical applications.
- Continued exploration of bacterial diversity, particularly understudied phyla like Planctomycetes, is essential for future bioprospecting.
- The 10-year timeframe for current progress underscores the urgency to begin investigating other promising bacterial phyla today.
Related Concept Videos
Bacterial Phylum Planctomycetes
Bacterial Phylum Tenericutes
Bacterial Phylum Actinobacteria
Bacterial Phylum Verrucomicrobiota
Bacterial Phylum Bacteroidota
Bacterial Phylum Proteobacteria

